Retinoic Acid and Polyriboinosinic:Polyribocytidylic Acid Stimulate Robust Anti-Tetanus Antibody Production while Differentially Regulating Type 1/Type 2 Cytokines and Lymphocyte Populations
Open Access
- 15 June 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 174 (12) , 7961-7969
Abstract
Retinoic acid (RA), a bioactive retinoid, and polyriboinosinic:polyribocytidylic acid (PIC) are known to promote immunity in vitamin A-deficient animals. In this study, we hypothesized that RA, PIC, and the combination can provide significant immunoadjuvant activity even in the vitamin A-adequate state. Six-week-old C57BL/6 mice were immunized with tetanus toxoid (TT) and treated with RA and/or PIC at priming in three independent studies of short and long duration. RA and PIC differentially regulated both primary and secondary anti-TT IgG isotypes, whereas the combination of RA + PIC stimulated the highest level of anti-TT IgG production and, concomitantly, a ratio of IgG1 to IgG2a similar to that of the control group. The regulation of Ab response was strongly associated with type 1/type 2 cytokine gene expression. Whereas RA reduced type 1 cytokines (IFN-γ and IL-12), PIC enhanced both type 1 and type 2 cytokines (IL-4 and IL-12) and cytokine-related transcription factors. Despite the presence of PIC, the IL-4:IFN-γ ratio was significantly elevated by RA. In addition, RA and/or PIC modulated NK/NKT cell populations and the level of expression of the costimulatory molecules CD80/CD86, evident 3 days after priming. Notably, the NKT:NK and CD80:CD86 ratios were correlated with the IL-4:IFN-γ ratio, indicative of multiple converging modes of regulation. Overall, RA, PIC, and RA + PIC rapidly and differentially shaped the anti-tetanus Ig response. The robust, durable, and proportionate increase in all anti-TT IgG isotypes induced by RA + PIC suggests that this combination is promising as a means to enhance the Ab response to TT and similar vaccines.Keywords
This publication has 47 references indexed in Scilit:
- All-Trans Retinoic Acid and Interferon-α for Treatment of Human Renal Cell Carcinoma Multicellular Tumor SpheroidsUrologia Internationalis, 2004
- The lineage decisions of helper T cellsNature Reviews Immunology, 2002
- Opposing cytokine‐specific effects of all trans‐retinoic acid on the activation and expression of signal transducer and activator of transcription (STAT)‐1 in THP‐1 cellsImmunology, 2002
- All‐trans‐retinoic acid and polyriboinosinic : polyribocytidylic acid in combination potentiate specific antibody production and cell‐mediated immunityImmunology, 2001
- VITAMINA, INFECTION,ANDIMMUNEFUNCTION*Annual Review of Nutrition, 2001
- Retinoic Acid and Polyriboinosinic Acid Act Synergistically to Enhance the Antibody Response to Tetanus Toxoid during Vitamin A Deficiency: Possible Involvement of Interleukin‐2 Receptor‐β, Signal Transducer and Activator of Transcription‐1, and Interferon Regulatory Factor‐1The Journal of Infectious Diseases, 2000
- Long-term Treatment of Malignant Gliomas with Intramuscularly Administered Polyinosinic-Polycytidylic Acid Stabilized with Polylysine and Carboxymethylcellulose: An Open Pilot StudyNeurosurgery, 1996
- Polyinosinic acid: polycytidylic acid promotes T helper type 1‐specific immune responses by stimulating macrophage production of interferon‐α and interleukin‐12European Journal of Immunology, 1995
- Effect of vitamin A supplementation on diarrhoea and acute lower-respiratory-tract infections in young children in BrazilThe Lancet, 1994
- Production of Interferon-α Induced by dsRNA in Human Peripheral Blood Mononuclear Cell Cultures: Role of Priming by dsRNA-Induced Interferons-γ and -βJournal of Interferon Research, 1989